Logo Image
|Articles|January 1, 2002

Supplements and Featured Publications

  • Symposium Reporter - Lipid Management
  • Volume 8
  • Issue 1 Symp

Dyslipidemia of Insulin Resistance Syndrome Explained; Need for Treatment to Reduce Risk Emphasized

Download PDF: Dyslipidemia of Insulin Resistance Syndrome Explained; Need for Treatment to Reduce Risk Emphasized

Articles in this issue

over 24 years ago

Cholesterol Goals Established for Patients with Diabetes and Metabolic Syndrome

over 24 years ago

Review of Clinical trial Data Reaffirms Safety of Statin Therapy

over 24 years ago

Protective Effects of HDL-C and Need to Raise Low Levels Explored

over 24 years ago

Risk Factors Common to Insulin Resistance and Atherosclerosis Explain Why Diabetes is a Cardiovascular Disease

over 24 years ago

Question and Answer

over 24 years ago

Heart Protection Study Finds Simvastatin Reduces Vascular Risk in a Wide Range of High-Risk Patients

over 24 years ago

Lipid-Lowering Therapy Stabilizes Plaque Reduces Events by Limiting Inflammation

over 24 years ago

New Cholesterol Guidelines Emphasize Risk Assessment

Related Content